Orthopedic management of spasticity in cerebral palsy.

Orthopedic management of spasticity in cerebral palsy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Orthopedic management of spasticity in cerebral palsy. Abstract Text:

Tom F Novacheck,James R Gage,Tom F Novacheck,James R Gage,

INTRODUCTION: This article summarizes our experience with cerebral palsy. The primary and secondary deformities that occur with cerebral palsy are described, followed by a brief overview of the nature and role of gait analysis in the treatment of gait problems in cerebral palsy. The concept of lever-arm dysfunction is introduced. DISCUSSION: Our current treatment program is then presented and subsequently illustrated by two case examples. Finally, an outcomes analysis of a group of patients with spastic diplegia treated with selective dorsal rhizotomy is presented to illustrate our current method of evaluating treatment outcomes and the need for team management in the treatment of this complex condition.

Orthopedic management of spasticity in cerebral palsy. Publishing Authors By Initials

TF Novacheck,JR Gage,TF Novacheck,JR Gage,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Orthopedic management of spasticity in cerebral palsy. Journal Published:

PUBLICATION TYPE: Review

Journal: Child's nervous system : ChNS : official journal o

VOLUME: 23

Page Numbers: 1015-31

Journal Abbreviation:

ISSN: 0256-7040

DAY: 12

MONTH: 07

YEAR: 2007

Orthopedic management of spasticity in cerebral palsy. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8503227

Orthopedic management of spasticity in cerebral palsy. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Orthopedic management of spasticity in cerebral palsy. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Orthopedic management of spasticity in cerebral palsy.

AFFILIATION: Gillette Children's Specialty Healthcare, 200 University Avenue E., St. Paul, MN 55101, USA. Novac001@umn.edu

Country: Germany

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Childs Nerv Syst

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Orthopedic management of spasticity in cerebral palsy Related Publications

• A STUDY OF THE HYGIENIC CONDITION OF THE AIR IN CERTAIN TEXTILE MILLS WITH REFERENCE TO THE INFLUENCE OF ARTIFICIAL HUMIDIFICATION.
• A STUDY OF THE HYGIENIC CONDITION OF THE AIR IN CERTAIN TEXTILE MILLS WITH REFERENCE TO THE INFLUENCE OF ARTIFICIAL HUMIDIFICATION.
• A functional study of miR-124 in the developing neural tube.
• Acamprosate efficacy in alcohol-dependent patients: summary of results from three pivotal trials.
• Aerial Nuisances from the Refining and Burning of Petroleum Oils.
• Alternative splicing events identified in human embryonic stem cells and neural progenitors.
• Applicability of techniques of military malaria control to industrial developments and rural populations.
• Barriers to the utilization of maternal health care in rural Mali.
• Climate change effects on plague and tularemia in the United States.
• Evaluation of commercial platforms for rapid genotyping of polymorphisms affecting therapeutic warfarin dose.
• Evolutionary conflicts: rapid suppression of a male-killer.
• Genetic-based dosing in orthopedic patients beginning warfarin therapy.
• Human plague in the southwestern United States, 1957-2004: spatial models of elevated risk of human exposure to Yersinia pestis.
• Multiple mortality optima due to heterogeneity in the birth cohort: a continuous model of birth weight by gestational age-specific infant mortality.
• NOTES ON THE EXAMINATION OF SOFT CLAMS FOR POLLUTION.
• Optimal dose adjustment in orthopedic patients beginning warfarin therapy.
• Optimal initial dose adjustment of warfarin in orthopedic patients.
• Orthopedic management of spasticity in cerebral palsy.
• Pharmacogenetic dose adjustments in orthopedic patients beginning warfarin therapy.
• Pharmacogenetic dose refinement prevents warfarin overdose in a patient who is highly warfarin-sensitive.
• Pharmacogenetics-based coumarin therapy.
• Quantification of MR brain images by mixture density and partial volume modeling.
• Report of the Committee on Bathing Places.
• Short term status epilepticus in rats causes specific behavioral impairments related to substantia nigra necrosis.
• Susceptibility of the black-legged tick, Ixodes scapularis, to the Lyme disease spirochete, Borrelia burgdorferi.
• Synapse formation on neurons born in the adult hippocampus.
• Synthetic antimalarials; physicochemical studies on pyrimidine derivatives.
• The globalization of veterinary medical education.
• The necessary junk: new functions for transposable elements.
• Use of mass transport to reduce surface roughness in replicated gallium phosphide refractive microlenses.